Belgium’s biotech sector confronts access challenges beyond rare diseases

EURACTIV - Despite Belgium's prominent position as Europe's second-largest biotech industry and its significant achievements in medical innovation, the pursuit of fast and sustainable access to life-saving therapies remains problematic, for Belgium and Europe. Read more

Photo courtesy of Argenx